SCHEMBL7958433

SCHEMBL7958433

CC(C)(C)c1ccc(COc2ccc(/C=C3/SC(=S)NC3=O)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 1/20 0.73
MMP13 P45452 1/20 0.73
CTSD P07339 3/20 0.66
PTPN1 P18031 3/20 0.65
HPGD P15428 4/20 0.63
ADAMTS5 Q9UNA0 3/20 0.61
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
MYC P01106 1/20 0.59
MAX P61244 1/20 0.59
CSNK2A2 P19784 1/20 0.59
CLK1 P49759 1/20 0.59
CSNK2B P67870 1/20 0.59
CSNK2A1 P68400 1/20 0.59
DYRK1A Q13627 1/20 0.59
DYRK1B Q9Y463 1/20 0.59
POLB P06746 1/20 0.59
MAOA P21397 1/20 0.59
MAOB P27338 1/20 0.59
PTGS2 P35354 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048467 1.00 MMP3 (0.73) MMP3MMP13CTSDPTPN1HPGD
SCHEMBL4048463 1.00 MMP3 (0.73) MMP3MMP13CTSDPTPN1HPGD
SCHEMBL7975174 0.90 MMP3 (0.69) MMP3MMP13CTSDPTPN1HPGD
SCHEMBL7975177 0.90 MMP3 (0.69) MMP3MMP13CTSDPTPN1HPGD
SCHEMBL29518356 0.90 MEN1 (0.67) MMP3MMP13HPGDADAMTS5NPC1
SCHEMBL4058937 0.89 PTPN1 (0.83) MMP3MMP13CTSDPTPN1HPGD
SCHEMBL4058938 0.89 PTPN1 (0.83) MMP3MMP13CTSDPTPN1HPGD
SCHEMBL4050763 0.87 HPGD (0.82) MMP3MMP13CTSDPTPN1HPGD
SCHEMBL4056380 0.87 HPGD (0.82) MMP3MMP13CTSDPTPN1HPGD
SCHEMBL4050762 0.87 HPGD (0.82) MMP3MMP13CTSDPTPN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251928-B1 ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0677517-A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D ELI LILLY AND COMPANY (US) 1995-10-18 EP disclosed